Skip to main content
Optomed Oyj logo

Optomed Oyj — Investor Relations & Filings

Ticker · OPTOMED ISIN · FI4000410881 LEI · 7437009IVYWGEE4S7B77 HE Manufacturing
Open in API
Filings indexed 613 across all filing types
Latest filing 2025-08-08 Director's Dealing
Country FI Finland
Listing HE OPTOMED

About Optomed Oyj

https://www.optomed.com/

Optomed is a medical technology company that develops, commercializes, and manufactures handheld fundus cameras and related artificial intelligence (AI) solutions. The company specializes in portable retinal imaging devices designed for the early detection of blinding eye diseases, such as diabetic retinopathy, and other health conditions. Its technology combines portable hardware with AI-powered software to provide real-time analysis and results, enabling comprehensive eye screenings in various healthcare settings, from primary care clinics to emergency rooms. The solutions are designed to integrate into existing clinical workflows, improving access to eye care and transforming routine screenings into comprehensive health assessments.

Recent filings

Filing Released Lang Actions
Optomed Oyj - Johdon liiketoimet - Badlani
Director's Dealing Classification · 100% confidence The document is titled 'Johdon liiketoimet' (Management Transactions) and details a specific share transaction by a board member (Sameer Badlani) of Optomed Oyj. It includes standard fields for insider trading disclosures such as the person's role, the instrument type (share), the nature of the transaction (receipt of share-based incentive), and transaction volume. This fits the definition of a Director's Dealing report.
2025-08-08 Finnish
Muutos Optomedin omien osakkeiden omistuksessa
Transaction in Own Shares Classification · 100% confidence The document is a stock exchange release (Pörssitiedote) from Optomed Oyj regarding the transfer of treasury shares to board members as part of their annual remuneration. This constitutes a company buying back or selling/transferring its own shares, which falls under the 'Transaction in Own Shares' category.
2025-08-08 Finnish
Optomedin taloudellinen raportointi 2026
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1752 characters) from Optomed Oyj detailing the scheduled dates for the publication of their 2026 financial reports (annual, interim, and half-year) and the planned date for the Annual General Meeting. It does not contain the actual financial reports themselves, but rather serves as a calendar/schedule announcement. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-08-07 Finnish
Optomed's financial reporting in 2026
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1894 characters) from Optomed Plc detailing the scheduled release dates for its upcoming financial reports (Financial Statement Bulletin, Interim Reports, Half-Year Report) and the planned date for the Annual General Meeting in 2026. It does not contain the actual financial results or the reports themselves, but rather serves as a calendar/schedule notification. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-08-07 English
Optomed Oyj:n puolivuosikatsaus, Tammi-kesäkuu 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'puolivuosikatsaus' (half-year report) for Optomed Oyj for the period January-June 2025. It contains comprehensive financial statements, key performance indicators (KPIs), management commentary, and operational updates. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-07 Finnish
Optomed Plc: Half-year Report, January - June 2025
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-year Report' for Optomed Plc covering the period January - June 2025. It contains comprehensive financial statements, key performance indicators (revenue, EBITDA, EBIT, cash flow), segment analysis, and a CEO review. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.